Charged residues dominate a unique interlocking topography in the heterodimeric cytokine interleukin-12

被引:140
|
作者
Yoon, C
Johnston, SC
Tang, J
Stahl, M
Tobin, JF
Somers, WS
机构
[1] Wyeth Ayerst Res, Dept Biol Chem, Cambridge, MA 02140 USA
[2] Wyeth Ayerst Res, Dept Musculoskeletal Sci, Cambridge, MA 02140 USA
来源
EMBO JOURNAL | 2000年 / 19卷 / 14期
关键词
cytokine-receptor complex; interleukin-12; structure-function; X-ray crystallography;
D O I
10.1093/emboj/19.14.3530
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human interleukin-12 (IL-12, p70) is an early proinflammatory cytokine, comprising two disulfide-linked subunits, p35 and p40. We solved the crystal structures of monomeric human p40 at 2.5 Angstrom and the human p70 complex at 2.8 Angstrom resolution, which reveals that IL-12 is similar to class 1 cytokine-receptor complexes. They also include the first description of an N-terminal immunoglobulin-like domain, found on the p40 subunit, Several charged residues from p35 and p40 intercalate to form a unique interlocking topography, shown by mutagenesis to be critical for p70 formation, A central arginine residue from p35 projects into a deep pocket on p40, which may be an ideal target for a small molecule antagonist of IL-12 formation.
引用
收藏
页码:3530 / 3541
页数:12
相关论文
共 50 条
  • [1] Charged residues dominate a unique interlocking topography in the interface of the heterodimeric cytokine Interleukin-12
    Yoon, C
    Johnston, SC
    Tang, J
    Stahl, M
    Tobin, JF
    Somers, WS
    FASEB JOURNAL, 2000, 14 (06): : A1183 - A1183
  • [2] Interleukin-12: A proinflammatory cytokine with immunoregulatory functions
    Trinchieri, G
    Scott, P
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 423 - 431
  • [3] Interleukin-12: A cytokine at the interface of inflammation and immunity
    Trinchieri, G
    ADVANCES IN IMMUNOLOGY, VOL 70, 1998, 70 : 83 - 243
  • [4] Interleukin-12 an integral cytokine in the immune response
    Stern, AS
    Magram, J
    Presky, DH
    LIFE SCIENCES, 1996, 58 (08) : 639 - 654
  • [5] Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: In vitro and in vivo production of biologically active interleukin-12
    Bramson, J
    Hitt, M
    Gallichan, WS
    Rosenthal, KL
    Gauldie, J
    Graham, FL
    HUMAN GENE THERAPY, 1996, 7 (03) : 333 - 342
  • [6] INTERLEUKIN-12 - A NEW CLINICAL PLAYER IN CYTOKINE THERAPY
    BANKS, RE
    PATEL, PM
    SELBY, PJ
    BRITISH JOURNAL OF CANCER, 1995, 71 (04) : 655 - 659
  • [7] Interleukin-12, an emerging anti-tumour cytokine
    Hiscox, S
    Jiang, WG
    IN VIVO, 1997, 11 (02): : 125 - 132
  • [8] Interleukin-12 to interleukin ‘infinity’: the rationale for future therapeutic cytokine targeting
    E. J. R. Anderson
    M. A. McGrath
    T. Thalhamer
    I. B. McInnes
    Springer Seminars in Immunopathology, 2006, 27 : 425 - 442
  • [9] Interleukin-12 to interleukin 'infinity': the rationale for future therapeutic cytokine targeting
    Anderson, E. J. R.
    McGrath, M. A.
    Thalhamer, T.
    McInnes, I. B.
    SPRINGER SEMINARS IN IMMUNOPATHOLOGY, 2006, 27 (04): : 425 - 442
  • [10] Interleukin-12, a new anti-tumor cytokine
    Mier, JW
    Gollob, JA
    Atkins, MB
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 1998, 11 (03) : 109 - 115